Publications

Lipoprotein Associated Phospholipase A2 (Lp-PLA2) as Emerging Cardiovascular Marker

Scientist from the MES Medical College (Malappuram, India) investigated the role of Lp-PLA2 in predicting cardiovascular diseases, using the high performance Lp-PLA2 reagent from DiaSys. The results were presented on the 2nd India International Science Festival 2016.

Download

An enzymatic Lp-PLA2 assay for fully automated analysis: A valuable supplementation to currently used cardiovascular risk assessment (2014)

 Download Lp-PLA2 Poster

Presentations & Conferences

8th Congress of the Croatian Society of Medical Biochemistry and Laboratory Medicine in September 2015

DiaSys distributor in Croatia, BigBlue participated in this event which took place in Rijeka, Croatia. Beside the industrial exhibition, BigBlue organized a workshop on the cardio-renal syndrome in which Lp-PLA2 was presented as a valuable biomarker which enables early detection of vulnerable plaques in high risk patients. Interested participants took the opportunity to address their requests and collected information on other parameters which contribute to the cardio-renal syndrome.

41st National Conference of Association of Clinical Biochemists, India, December 2014

DiaSys India exhibited in two of the prominent Indian Exhibitions for Diagnostics. One was the 63rd Annual Conference of the Indian Association of Pathologists and Microbiologists (IAPM) and the Annual Conference of the International Academy of Pathology-Indian Division (IAP-ID) held at the Armed Forces Medical College, Pune from the 4th to 7th of December. Second the 41st National Conference of Association of Clinical Biochemists of India at the All India Institute of Medical Sciences, Jodhpur from the 10th to 13th of December.

DiaSys India was present in the associated industry exhibition presenting the product portfolio for diagnostic system solutions, point-of-care testing and automated laboratory systems.

During the conference, the DiaSys team had the opportunity to present the new parameter Lp-PLA2. More than 80 participants followed the presentation which was held and supported by DiaSys Product Manager Irene Delseith; the half an hour session was appreciated and followed with great interest by the audience.

IFCC Worldlab, Istanbul, June 2014

During the IFCC Worldlab in Istanbul, DiaSys offered a workshop on Lp-PLA2 which attracted more than 100 participants showing great interest in this new parameter. DiaSys presented two distinguished experts on the field of lipid diagnosis and atherosclerosis: Prof. Dr. Hubert Scharnagl, Clinical Institute of Medical and Chemical Laboratory, Medical University of Graz, Austria and Dr. Marcus Michael Hoffmann, Department of Medicine, University of Freiburg, Germany who gave a comprehensive overview on the role of Lp-PLA2 in risk assessment of cardiovascular disease and as a predictor of coronary artery disease events. Irene Delseith, responsible Product Manager at DiaSys talked on the technological aspect of Lp-PLA2 measurement and introduced the assay. The audience appreciated much learning on theoretical background, important study results and practical applications of the new test.

LABKVALITA, Slovakia, October 2013

Our distributor Bio-G in Slovakia exhibited at this Biennial Conference of the Slovak Society of Clinical Biochemistry which took place in Štrbské Pleso from October 6 – 8, 2013. During this event, DiaSys Product Manager Ms Irene Delseith held a lecture on Lp-PLA2 entitled "Closing the diagnostic gap in cardiovascular risk assessment".

The subsequent discussion among present experts, led by P. Blažíček, Bratislava, showed that this new biomarker is seen as a valuable tool in cardiovascular risk assessment. The introduction of the easy-to-use DiaSys test was highly welcomed and interested participants took the opportunity to collect more information on the DiaSys product in the parallel industry exhibition.